Pharos Capital Group

Pharos was founded in 1998 by physicians, though the firm has not publicly disclosed its current leadership team or investment committee structure. The founding clinical orientation implies that healthcare practitioners were central to early investment decisions, but the composition of the present-day decision-making body is not available in primary sources.

Sourcing is inferred to rely on the firm's physician-founded network and longstanding presence in Dallas and Nashville, two major U.S. healthcare hubs. The firm's website does not detail a formal origination strategy, but its consistent focus on provider-led, cost-reduction-oriented businesses suggests that relationships within clinical and hospital-administration circles drive proprietary opportunities.

Pharos is structured as a private equity firm, not a family office or a venture capital platform. It makes buyout and growth-stage investments in lower-middle-market healthcare companies, writing equity checks in the $25 million to $50 million range, a posture distinct from early-stage venture or passive family capital management.

Pharos focuses on direct private equity investments in healthcare companies. There is no publicly available indication that the firm commits capital as a limited partner to external funds, nor evidence of a fund-of-funds program. Its disclosed activity confirms a direct, control-oriented investment model.

The firm targets growth-stage and expansion-stage healthcare companies, along with buyout, recapitalization, and restructuring opportunities. This stage-agnostic flexibility within the lower middle market allows Pharos to deploy capital across a company's lifecycle, from early growth to mature operational turnarounds, all within healthcare services and technology.